Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This manuscript proposes an automatic reading detection system for an analogue gauge using a combination of deep learning, machine learning, and image processing. The study suggests image-processing techniques in manual analogue gauge reading that include generating readings for the image to provide supervised data to address difficulties in unsupervised data in gauges and to achieve better accuracy using DenseNet 169 compared to other approaches. The model uses artificial intelligence to automate reading detection using deep transfer learning models like DenseNet 169, InceptionNet V3, and VGG19. The models were trained using 1011 labeled pictures, 9 classes, and readings from 0 to 8. The VGG19 model exhibits a high training precision of 97.00% but a comparatively lower testing precision of 75.00%, indicating the possibility of overfitting. On the other hand, InceptionNet V3 demonstrates consistent precision across both datasets, but DenseNet 169 surpasses other models in terms of precision and generalization capabilities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449899PMC
http://dx.doi.org/10.1038/s41598-024-71270-0DOI Listing

Publication Analysis

Top Keywords

reading detection
12
densenet 169
12
deep transfer
8
transfer learning
8
gauge reading
8
analogue gauge
8
computer vision
4
vision deep
4
learning
4
learning automatic
4

Similar Publications

Purpose: To evaluate inter-grader variability in posterior vitreous detachment (PVD) classification in patients with epiretinal membrane (ERM) and macular hole (MH) on spectral-domain optical coherence tomography (SD-OCT) and identify challenges in defining a reliable ground truth for artificial intelligence (AI)-based tools.

Methods: A total of 437 horizontal SD-OCT B-scans were retrospectively selected and independently annotated by six experienced ophthalmologists adopting four categories: 'full PVD', 'partial PVD', 'no PVD', and 'ungradable'. Inter-grader agreement was assessed using pairwise Cohen's kappa scores.

View Article and Find Full Text PDF

Background: Lateral malleolar avulsion fracture (LMAF) and subfibular ossicle (SFO) are distinct entities that both present as small bone fragments near the lateral malleolus on imaging, yet require different treatment strategies. Clinical and radiological differentiation is challenging, which can impede timely and precise management. On imaging, magnetic resonance imaging (MRI) is the diagnostic gold standard for differentiating LMAF from SFO, whereas radiological differentiation on computed tomography (CT) alone is challenging in routine practice.

View Article and Find Full Text PDF

Objective: Present study aimed to determine the demographic, epidemiological and pathological features of human cystic echinococcosis (CE) cases using patients' hospital based clinical history from 2012-2023.

Methods: The current retrospective study was conducted from June-December and aimed to investigate the incidence of human CE in Pakistan. A total of 74 surgically confirmed patients' data was retrieved from the hospital records.

View Article and Find Full Text PDF

Background: One of the most important points in the treatment of food allergies is the avoidance of the culprit allergen. This study aimed to determine whether the training given by a dietitian to mothers of children with IgE-mediated food allergies increased the habit of reading food labels.

Methods: Mothers of children with IgE-mediated food allergies were trained on reading food labels by a dietitian.

View Article and Find Full Text PDF

Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.

Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.

Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).

View Article and Find Full Text PDF